Report finds Americans with long COVID losing billions in wages, as Moderna sues Pfizer and BioNTech over mRNA patents
admin Some 16 million Americans of working age have long-term COVID and as many as 4…
Read MoreWholesalers
Study finds Pfizer’s antiviral has little or even zero benefit for younger adults, and WHO says BA.5 omicron subvariant accounted for 74% of cases in latest week
Pfizer’s COVID antiviral Paxlovid appears to have little or no benefit for younger adults, although…
Read MoreOmicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorization
Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day,…
Read MoreOmicron-specific boosters could be rolled out after Labor Day: report
Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day,…
Read MorePfizer and BioNTech say data show COVID vaccine has more than 70% efficacy in small children, with cases now rising in just 7 states
Pfizer and German partner BioNTech on Tuesday offered updated COVID vaccine data supporting efficacy in…
Read MoreJill Biden leaves isolation after twice testing negative, and Novavax vaccine is now allowed for U.S. teens
First lady Jill Biden left isolation on Sunday, after testing negative for COVID twice and…
Read MoreWhat will insurance coverage of COVID-19 vaccines and treatments look like? The Biden administration is trying to figure that out
Get ready for a big change in how the U.S. will pay for COVID-19 vaccines…
Read MoreLarge-scale study finds COVID patients at higher risk of brain fog and psychosis after two years compared with other respiratory illnesses
People who have had COVID-19 are facing a higher risk of neurological and psychiatric conditions…
Read MoreU.K. regulator is first to authorize Moderna’s bivalent COVID booster for 18-and-older population
The U.K. regulator has become the first to authorize Moderna’s bivalent COVID vaccine booster for…
Read More
20 value stocks whose growth potential is overlooked by investors
After a years-long bull market in growth stocks, the beleaguered value strategy has outperformed this…
Read More